Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Accounts Payables (2017 - 2025)

Catheter Precision (VTAK) has disclosed Accounts Payables for 9 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Accounts Payables rose 52.4% to $1.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.1 million, a 52.4% increase, with the full-year FY2024 number at $230000.0, down 50.43% from a year prior.
  • Accounts Payables was $1.1 million for Q3 2025 at Catheter Precision, up from $804000.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $1.2 million in Q1 2022 to a low of $92000.0 in Q4 2022.
  • A 5-year average of $636000.0 and a median of $613500.0 in 2023 define the central range for Accounts Payables.
  • Peak YoY movement for Accounts Payables: crashed 90.69% in 2022, then skyrocketed 789.25% in 2024.
  • Catheter Precision's Accounts Payables stood at $988000.0 in 2021, then plummeted by 90.69% to $92000.0 in 2022, then soared by 404.35% to $464000.0 in 2023, then plummeted by 50.43% to $230000.0 in 2024, then skyrocketed by 369.13% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Accounts Payables are $1.1 million (Q3 2025), $804000.0 (Q2 2025), and $647000.0 (Q1 2025).